Related Experiment Video
Updated: Aug 9, 2026
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
ECT for major depression and mania with advanced dementia
1Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Kentucky, USA.
The Journal of ECT
|April 3, 2001
Summary
Electroconvulsive therapy (ECT) effectively treated severe affective disorders in two dementia patients without adverse effects. This demonstrates ECT
Area of Science:
- Geriatric Psychiatry
- Neuroscience
- Neurology
Background:
- Advanced dementia often presents with severe affective disorders, posing treatment challenges.
- Treatment options for mood disorders in dementia patients are limited.
- Electroconvulsive therapy (ECT) is a potent neuromodulation technique.
Observation:
- Two patients with advanced dementia and severe depression/mania were treated with ECT.
- Treatment was administered without significant adverse events.
- Both patients showed successful symptom remission.
Findings:
- Electroconvulsive therapy (ECT) can be a safe and effective treatment for depression and mania in patients with moderate to severe dementia.
- ECT may offer a viable therapeutic option for complex neuropsychiatric conditions.
- Neuromodulation via ECT can address severe mood disturbances in neurodegenerative diseases.
Implications:
- These findings suggest ECT should be considered for managing severe affective symptoms in dementia.
- Further research into ECT's efficacy and safety in dementia populations is warranted.
- ECT may improve quality of life for individuals with dementia and co-occurring mood disorders.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...